191 related articles for article (PubMed ID: 19269762)
21. Handheld array-based photoacoustic probe for guiding needle biopsy of sentinel lymph nodes.
Kim C; Erpelding TN; Maslov K; Jankovic L; Akers WJ; Song L; Achilefu S; Margenthaler JA; Pashley MD; Wang LV
J Biomed Opt; 2010; 15(4):046010. PubMed ID: 20799812
[TBL] [Abstract][Full Text] [Related]
22. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate.
Wong SL; Edwards MJ; Chao C; Tuttle TM; Noyes RD; Carlson DJ; Cerrito PB; McMasters KM
J Am Coll Surg; 2001 Jun; 192(6):684-9; discussion 689-91. PubMed ID: 11400961
[TBL] [Abstract][Full Text] [Related]
23. Final results of the Department of Defense multicenter breast lymphatic mapping trial.
Shivers S; Cox C; Leight G; Beauchamp D; Blumencranz P; Ross M; Reintgen D
Ann Surg Oncol; 2002 Apr; 9(3):248-55. PubMed ID: 11923131
[TBL] [Abstract][Full Text] [Related]
24. Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed?
McMasters KM; Reintgen DS; Ross MI; Wong SL; Gershenwald JE; Krag DN; Noyes RD; Viar V; Cerrito PB; Edwards MJ
Ann Surg Oncol; 2001 Apr; 8(3):192-7. PubMed ID: 11314933
[TBL] [Abstract][Full Text] [Related]
25. [Preliminary study on a new sentinel lymphoscintigraphy agent 99mTc-Rituximab for breast patient].
Wang XJ; Lin BH; Yang Z; Ouyang T; Li JF; Xu B; Zhang Y; Zhang MY
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):200-3. PubMed ID: 16875605
[TBL] [Abstract][Full Text] [Related]
26. Perinodal fibrosis developed after ultrasonography-guided core-needle biopsy of a contrast-enhanced ultrasound-detected sentinel axillary node interferes with subsequent surgical sentinel node dissection.
Serquiz N; Moro L; Menossi CA; Almeida NR; Baccarin G; de Paiva Silva GR; Shinzato JY; Derchain S; Jales RM
J Clin Ultrasound; 2019 Oct; 47(8):445-452. PubMed ID: 31359458
[TBL] [Abstract][Full Text] [Related]
27. Dual-Modality Noninvasive Mapping of Sentinel Lymph Node by Photoacoustic and Near-Infrared Fluorescent Imaging Using Dye-Loaded Mesoporous Silica Nanoparticles.
Liu Z; Rong P; Yu L; Zhang X; Yang C; Guo F; Zhao Y; Zhou K; Wang W; Zeng W
Mol Pharm; 2015 Sep; 12(9):3119-28. PubMed ID: 26132789
[TBL] [Abstract][Full Text] [Related]
28. Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
Foster D; Choy N; Porter C; Ahmed S; Wapnir I
J Surg Oncol; 2018 Mar; 117(3):336-340. PubMed ID: 29228459
[TBL] [Abstract][Full Text] [Related]
29. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
[TBL] [Abstract][Full Text] [Related]
30. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.
Cox CE; Pendas S; Cox JM; Joseph E; Shons AR; Yeatman T; Ku NN; Lyman GH; Berman C; Haddad F; Reintgen DS
Ann Surg; 1998 May; 227(5):645-51; discussion 651-3. PubMed ID: 9605656
[TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.
Kinoshita T; Takasugi M; Iwamoto E; Akashi-Tanaka S; Fukutomi T; Terui S
Am J Surg; 2006 Feb; 191(2):225-9. PubMed ID: 16442950
[TBL] [Abstract][Full Text] [Related]
32. Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy.
Han SN; Amant F; Cardonick EH; Loibl S; Peccatori FA; Gheysens O; Sangalli CA; Nekljudova V; Steffensen KD; Mhallem Gziri M; Schröder CP; Lok CAR; Verest A; Neven P; Smeets A; Pruneri G; Cremonesi M; Gentilini O;
Breast Cancer Res Treat; 2018 Apr; 168(2):551-557. PubMed ID: 29235045
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of the lymphoscintigraphy in the evaluation of non-axillary sentinel lymph node localization in breast cancer.
Gherghe M; Bordea C; Blidaru A
Chirurgia (Bucur); 2015; 110(1):26-32. PubMed ID: 25800312
[TBL] [Abstract][Full Text] [Related]
34. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
[TBL] [Abstract][Full Text] [Related]
35. Near infrared photoacoustic detection of sentinel lymph nodes with gold nanobeacons.
Pan D; Pramanik M; Senpan A; Ghosh S; Wickline SA; Wang LV; Lanza GM
Biomaterials; 2010 May; 31(14):4088-93. PubMed ID: 20172607
[TBL] [Abstract][Full Text] [Related]
36. Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes--one institution's experience.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Melanoma Res; 2003 Feb; 13(1):35-43. PubMed ID: 12569283
[TBL] [Abstract][Full Text] [Related]
37. Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm).
Di Martino G; Crivellaro C; De Ponti E; Bussi B; Papadia A; Zapardiel I; Vizza E; Elisei F; Diestro MD; Locatelli L; Gasparri ML; Di Lorenzo P; Mueller M; Buda A
J Minim Invasive Gynecol; 2017; 24(6):954-959. PubMed ID: 28571944
[TBL] [Abstract][Full Text] [Related]
38. Sentinel lymph node biopsy in early breast cancer: the first 100 cases performed in a teaching institute.
Mahajna A; Hershko DD; Israelit S; Abu-Salih A; Keidar Z; Krausz MM
Isr Med Assoc J; 2003 Aug; 5(8):556-9. PubMed ID: 12929292
[TBL] [Abstract][Full Text] [Related]
39. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
[TBL] [Abstract][Full Text] [Related]
40. Sentinel Node Mapping Using Indocyanine Green and Near-infrared Fluorescence Imaging Technology for Uterine Malignancies: Preliminary Experience With the Da Vinci Xi System.
Siesto G; Romano F; Fiamengo B; Vitobello D
J Minim Invasive Gynecol; 2016; 23(4):470-1. PubMed ID: 26767824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
